SAGE Therapeutics's total assets for Q4 2024 were $547.22M, a decrease of -12.08% from the previous quarter. SAGE total liabilities were $82.13M for the fiscal quarter, a 16.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.